Furthermore, the number of cells that passed through the chamber in the siPRNP+GEM group was even greater than that in the GEM group, suggesting that PRNP knockdown augments the inhibitory effect of gemcitabine on the migration of human pancreatic cancer cells (p < 0.05). The gene discussed is PRNP; the disease is familial pancreatic carcinoma.